Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Gefitinib can cause hair loss without scarring.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Targeting the Warburg effect in anaplastic thyroid carcinoma may reduce tumor growth and improve treatment.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Using Cetirizine 1% cream daily can significantly improve hair growth and thickness in men with hair loss, and it's safe to use.

Advanced dermoscopy techniques improve diagnosis and treatment monitoring for Kerion celsi but don't guarantee full hair regrowth.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Bimekizumab effectively treated a man's chronic beard hair loss.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Using ultrasound may make cisplatin more effective against cervical cancer in mice.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

MVP treatment is effective and safe for recurrent breast cancer.

The document lists research on Pemetrexed and Cisplatin for lung cancer but doesn't give a final conclusion.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.